KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 158 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 4.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $611,000 | -31.2% | 58,053 | +1.2% | 0.00% | 0.0% |
| Q4 2020 | $888,000 | -27.6% | 57,384 | -31.6% | 0.00% | -50.0% |
| Q3 2020 | $1,226,000 | -30.7% | 83,947 | -10.1% | 0.00% | -33.3% |
| Q2 2020 | $1,769,000 | +665.8% | 93,395 | +136.3% | 0.00% | – |
| Q1 2019 | $231,000 | -85.3% | 39,529 | -76.5% | 0.00% | -100.0% |
| Q4 2018 | $1,576,000 | – | 168,170 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,827,078 | $82,205,000 | 4.43% |
| Palo Alto Investors LP | 4,663,324 | $79,416,000 | 3.21% |
| Private Capital Advisors, Inc. | 473,901 | $8,071,000 | 2.23% |
| DOHENY ASSET MANAGEMENT /CA | 215,445 | $3,669,000 | 1.92% |
| Sandia Holdings, LLC | 119,739 | $2,039,000 | 0.96% |
| Capital Impact Advisors, LLC | 102,006 | $1,744,000 | 0.60% |
| Birchview Capital, LP | 50,000 | $852,000 | 0.55% |
| EMERALD ADVISERS, LLC | 694,068 | $11,820,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 647,307 | $11,024,000 | 0.37% |
| Schonfeld Strategic Advisors LLC | 418,100 | $7,121,000 | 0.32% |